Concepedia

Amir Reza Aref

AR

Statistics

Publications

32

Citations

6.7K

H-Index

25

Active since

2013

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Massachusetts General Hospital

Broad Institute

Amir Reza Aref is an author at Dana-Farber Cancer Institute specializing in oncology, cancer immunotherapy, and medicine.

ORCID

Publications per year

2013–2025

32

Publications

32

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard et al. · Cell · 2018 · 2K citations · Full text

, , +14

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

Jiehui Deng, Eric S. Wang, Russell W. Jenkins et al. · Cancer Discovery · 2017 · 781 citations · Full text

, , +17

STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor Microenvironment

Shohei Koyama, Esra A. Akbay, Yvonne Y. Li et al. · Cancer Research · 2016 · 630 citations · Full text

, , +17

<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 585 citations

, , +17

Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy

Qiang Lü, Dongquan Kou, Shenghan Lou et al. · Journal of Hematology & Oncology · 2024 · 333 citations · Full text

, , +17

1–5 of 32